Ductal Carcinoma In Situ : What the Pathologist Needs to Know and Why
Author
Source
International Journal of Breast Cancer
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-02-06
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Ductal carcinoma in situ is a proliferation of malignant epithelial cells confined to the ductolobular system of the breast.
It is considered a pre-cursor lesion for invasive breast cancer and when identified patients are treated with some combination of surgery, +/− radiation therapy, and +/adjuvant tamoxifen.
However, no good biomarkers exist that can predict with accuracy those cases of DCIS destined to progress to invasive disease or once treated those patients that are likely to suffer a recurrence; thus, in the era of screening mammography it seems likely that many patients with DCIS are overtreated.
This paper details the parameters that should be included in a pathology report for a case of DClS with some explanations as to their importance for good clinical decision making.
American Psychological Association (APA)
Bane, Anita. 2013. Ductal Carcinoma In Situ : What the Pathologist Needs to Know and Why. International Journal of Breast Cancer،Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-507639
Modern Language Association (MLA)
Bane, Anita. Ductal Carcinoma In Situ : What the Pathologist Needs to Know and Why. International Journal of Breast Cancer No. 2013 (2013), pp.1-7.
https://search.emarefa.net/detail/BIM-507639
American Medical Association (AMA)
Bane, Anita. Ductal Carcinoma In Situ : What the Pathologist Needs to Know and Why. International Journal of Breast Cancer. 2013. Vol. 2013, no. 2013, pp.1-7.
https://search.emarefa.net/detail/BIM-507639
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-507639